A novel role of cytosolic protein synthesis inhibition in aminoglycoside ototoxicity

SP Francis, J Katz, KD Fanning, KA Harris… - Journal of …, 2013 - Soc Neuroscience
SP Francis, J Katz, KD Fanning, KA Harris, BD Nicholas, M Lacy, J Pagana, PF Agris…
Journal of Neuroscience, 2013Soc Neuroscience
Ototoxicity is a main dose-limiting factor in the clinical application of aminoglycoside
antibiotics. Despite longstanding research efforts, our understanding of the mechanisms
underlying aminoglycoside ototoxicity remains limited. Here we report the discovery of a
novel stress pathway that contributes to aminoglycoside-induced hair cell degeneration.
Modifying the previously developed bioorthogonal noncanonical amino acid tagging
method, we used click chemistry to study the role of protein synthesis activity in …
Ototoxicity is a main dose-limiting factor in the clinical application of aminoglycoside antibiotics. Despite longstanding research efforts, our understanding of the mechanisms underlying aminoglycoside ototoxicity remains limited. Here we report the discovery of a novel stress pathway that contributes to aminoglycoside-induced hair cell degeneration. Modifying the previously developed bioorthogonal noncanonical amino acid tagging method, we used click chemistry to study the role of protein synthesis activity in aminoglycoside-induced hair cell stress. We demonstrate that aminoglycosides inhibit protein synthesis in hair cells and activate a signaling pathway similar to ribotoxic stress response, contributing to hair cell degeneration. The ability of a particular aminoglycoside to inhibit protein synthesis and to activate the c-Jun N-terminal kinase (JNK) pathway correlated well with its ototoxic potential. Finally, we report that a Food and Drug Administration-approved drug known to inhibit ribotoxic stress response also prevents JNK activation and improves hair cell survival, opening up novel strategies to prevent and treat aminoglycoside ototoxicity.
Soc Neuroscience